Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab).
Kain
Sam
S
Copeland
Tandy-Sue
TS
Leahy
Michael F
MF
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab